Charles River Laboratories
561 hedge funds and large institutions have $13.6B invested in Charles River Laboratories in 2021 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 199 increasing their positions, 211 reducing their positions, and 49 closing their positions.
55% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 49
17% more capital invested
Capital invested by funds: $11.7B → $13.6B (+$1.96B)
13% more funds holding in top 10
Funds holding in top 10: 15 → 17 (+2)
4% more funds holding
Funds holding: 538 → 561 (+23)
0.57% more ownership
Funds ownership: 94.16% → 94.73% (+0.57%)
6% less repeat investments, than reductions
Existing positions increased: 199 | Existing positions reduced: 211
21% less call options, than puts
Call options by funds: $52.6M | Put options by funds: $66.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
+$239M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$138M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$125M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$62.4M |
| 5 |
BlackRock
New York
|
+$61.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$83.1M |
| 2 |
Renaissance Technologies
New York
|
-$70.7M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$67.1M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
-$59.8M |
| 5 |
EIP
Epoch Investment Partners
New York
|
-$59.5M |
CRL Hedge Fund Activity: Q1 2021 in Review
561 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2021, worth a combined $13.6B — up 17% from $11.7B a quarter earlier.
Buyers outnumbered sellers: 76 funds opened new CRL positions and 49 closed out — a net gain of 27 holders — while 199 added to existing stakes and 211 trimmed.
The largest buyer was William Blair Investment Management, adding an estimated $239M. The largest seller was Fidelity International, cutting an estimated $83.1M.
- 561 institutional investors held Charles River Laboratories (CRL) as of Q1 2021, up from 538 in Q4 2020.
- Funds reported $13.6B of Charles River Laboratories stock for Q1 2021, up 17% quarter-over-quarter.
- 76 funds opened new Charles River Laboratories positions in Q1 2021 and 49 closed out, a net change of +27 holders.
- The largest Charles River Laboratories buyer in Q1 2021 was William Blair Investment Management, an estimated $239M added.
- The largest Charles River Laboratories seller in Q1 2021 was Fidelity International, an estimated $83.1M sold.
Based on aggregated 13F filings for Q1 2021.